BEIJING, Apr 3, 2018 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a leading specialty hospital management solutions
provider and operator of a network of radiotherapy and diagnostic
imaging centers in China, today
announced that investment institutions led by CICC Capital
Management Company Limited ("CICC Capital"), a wholly-owned
subsidiary of China International Capital Corporation Limited
("CICC"), will make a strategic investment in Concord Medical's
subsidiary, Beijing Meizhong Jiahe Hospital Management Co., Ltd.
("Meizhong Jiahe"). The total investment will be RMB 1.5 to 1.8 billion. After completion of the
investment, the total shares held by these institutions led by CICC
Capital will account for 37.5% to 41.9% of the equity interests of
Meizhong Jiahe.
As the most important operating platform of Concord Medical in
China, Meizhong Jiahe has been
committed to investing in the operation of cancer diagnosis and
treatment centers nationwide. It has developed into a nationwide
hospital management group and a network of independent specialty
cancer hospitals located in Beijing, Shanghai and Guangzhou, with an emphasis on high-end
specialty cancer hospitals, including secondary specialty cancer
hospitals and proton therapy treatment. With the aim of ensuring
technical training, promoting medical quality and strengthening
hospital management, Meizhong Jiahe will provide high-quality
medical services for patients. Meizhong Jiahe is committed to
becoming a top brand for Chinese specialty cancer hospitals by
introducing international frontier medical research results,
multidisciplinary treatment models and hospital management
concepts.
Dr. Jianyu Yang, Chairman and
Chief Executive Officer of Concord Medical, commented, "As CICC
Capital is one of the most influential investment institutions in
China with a strong state-owned
background, we are excited and honored to have such a strong
strategic partner to make a significant investment in Meizhong
Jiahe. This is also an important milestone in the overall
strategic development of Concord Medical. This strategic investment
will provide strong financial support for Meizhong Jiahe and its
operations in China. We strongly
believe that Meizhong Jiahe will take this opportunity to invest
more firmly in the medical industry, focus on the Chinese
healthcare market and provide the latest international advanced
technologies. We also believe that Meizhong Jiahe offers
best-in-class clinical outcomes and caring services to our
patients."
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty
hospital management solution provider and operator of a network of
radiotherapy and diagnostic imaging centers in China. As of June 30,
2017, the Company operated a network of 60 centers with 41
hospital partners that spanned 34 cities and 19 provinces and
administrative regions in China.
Under long-term arrangements with top-tier hospitals in
China, the Company provides
radiotherapy and diagnostic imaging equipment and manages the daily
operations of these centers, which are located on the premises of
its hospital partners. The Company also provides ongoing training
to doctors and other medical professionals in its network of
centers to ensure a high level of clinical care for patients. For
more information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement, including the outcome of the investment
described above and other risk factors contained in the Company's
annual report on 20-F filed with the Securities and Exchange
Commission. The Company does not undertake any obligation to update
any forward-looking statement, except as required under applicable
law.
For more information, please contact:
Concord Medical Services
Ms. Carol TIAN (Chinese and English)
+86 10 5903 6688 (ext. 608)
yuan.tian@ccm.cn
View original
content:http://www.prnewswire.com/news-releases/concord-medical-welcomes-investment-led-by-china-international-capital-corporation-limited-300623215.html
SOURCE Concord Medical Services Holdings Limited